Navigation Links
European Union, State of Brandenburg, Award Grants to Alcat Europe, GmbH
Date:3/6/2008

HENNIGSDORF, Germany, March 6 /PRNewswire/ -- Recently the State of Brandenburg, and the EU, awarded two grants, valued at about 850,000 euro, to Alcat Europe, GmbH, covering marketing and employee costs during early years of operation.

Alcat Europe, a laboratory company located in the BioTech Park in Hennigsdorf (Berlin) engages in testing client blood samples for food and chemical sensitivities through the Alcat test method. The grants demonstrate the confidence the Brandenburg government has in the company's innovative technology, and the company's ability to fulfill the need for a reliable test to identify foods and chemicals associated with numerous health disorders.

"We are pleased that the EU and the State of Brandenburg recognize the importance of food intolerance for the health of the German public," stated Anja Noa Koch, Prokura of Alcat Europe.

Roger Deutsch, CEO of Alcat Europe and the parent US company, CSS, states, "We are grateful for this recognition as well as the substantial resource of highly qualified scientific institutions and personnel in the area to support our growth."

Alcat Europe, GmbH is a wholly owned subsidiary of Cell Science Systems, Ltd., Corp., (CSS) of Deerfield Beach, Florida (USA). CSS, CLIA licensed and registered with the US FDA as a device manufacturer, is a fully integrated medical and health technology company on the cutting edge of research, diagnosis and management of food and chemical sensitivities. CSS operates a lab and manufactures the hardware, software and reagent systems used in the performance of the Alcat test for world wide distribution.

The Alcat test (http://www.alcat.com) has been awarded three international patents. It is an accurate blood test for detecting delayed type reactions to foods, chemicals, and other substances, that manifest inflammatory conditions, such as; migraine, arthritis, skin and respiratory disorders, IBS, and the metabolic syndrome associated with heart disease, diabetes and obesity. A Baylor medical study reported a 98% success amongst its subjects rate in improving weight loss and body composition using the Alcat test. CSS intends to continue to expand its international customer base and build awareness about the health benefits to be derived by following an individually tailored eating plan.


'/>"/>
SOURCE Alcat
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
2. CT Laser Mammography Technology to be Featured at European Congress of Radiology
3. Boston Scientific Announces European Approval of New Heart Failure Lead
4. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
7. European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions
8. USC and second sight announce European clinical trial for Argus II retinal implant
9. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
10. AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
11. European Commission gives grant to investigate transatlantic oversight of nanotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, former senior ... the University of North Carolina Kenan-Flagler Business School effective June 27. ... Kenan-Flagler, with a focus on the school’s international efforts, leading classes and participating ...
(Date:6/24/2016)... -- Regular discussions on a range of subjects including policies, debt ... said Poloz. Speaking at a lecture to the ... pointed to the country,s inflation target, which is set by ... "In certain areas there needs to ... goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):